Firefly Neuroscience (NASDAQ:AIFF) Announces Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) announced its quarterly earnings results on Tuesday. The company reported ($0.07) earnings per share (EPS) for the quarter, FiscalAI reports. Firefly Neuroscience had a negative return on equity of 90.17% and a negative net margin of 506.23%. The company had revenue of $0.65 million during the quarter.

Firefly Neuroscience Stock Performance

Firefly Neuroscience stock traded up $0.02 during trading hours on Tuesday, hitting $0.97. 8,482 shares of the stock were exchanged, compared to its average volume of 3,883,084. The stock has a market capitalization of $15.27 million, a P/E ratio of -1.65 and a beta of 0.49. Firefly Neuroscience has a 12 month low of $0.62 and a 12 month high of $3.15. The business’s 50-day moving average is $1.14 and its two-hundred day moving average is $1.35.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on AIFF. Wall Street Zen downgraded shares of Firefly Neuroscience from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock has an average rating of “Sell”.

Hedge Funds Weigh In On Firefly Neuroscience

A hedge fund recently raised its position in Firefly Neuroscience stock. Cygnus Capital Advisors LLC increased its holdings in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 122.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 44,552 shares of the company’s stock after buying an additional 24,513 shares during the quarter. Cygnus Capital Advisors LLC owned 0.28% of Firefly Neuroscience worth $54,000 as of its most recent SEC filing. Institutional investors and hedge funds own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc is a digital health and neuroscience company focused on using artificial intelligence to support the assessment and treatment of brain disorders. The company develops technology designed to analyze electroencephalography (EEG) data and identify patterns associated with cognitive and psychiatric conditions.

Its principal platform, Brain Network Analytics (BNA), is intended to convert EEG recordings into clinically relevant measures of brain function. Firefly’s technology is designed to help healthcare professionals evaluate conditions such as Alzheimer’s disease and major depressive disorder, monitor changes in patients’ brain activity, and support more personalized treatment decisions.

Firefly Neuroscience became a publicly traded company on Nasdaq under the symbol AIFF following a business combination with WaveDancer, Inc in 2024.